Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge A Garcia

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Therapeutic Advances in Medical Oncology|July 27, 2011
Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologistsJorge A Garcia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Systemic chemotherapy for advanced bladder cancer: update and controversiesJorge A Garcia, Robert Dreicer
Molecular Cancer Therapeutics|June 21, 2008
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesJorge A Garcia, David Danielpour
Nature Clinical Practice. Urology|February 14, 2006
Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversiesJorge A Garcia, Robert Dreicer
Current Opinion in Urology|March 26, 2009
Complications of androgen deprivation therapy in prostate cancerAnita Schwandt, Jorge A Garcia
Oncology (Williston Park, N.Y.)|May 10, 2011
Immunotherapy in castration-resistant prostate cancer: integrating sipuleucel-T into our current treatment paradigmJorge A Garcia, Robert Dreicer
Current Oncology Reports|January 19, 2011
Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancerMohamed Salem, Jorge A Garcia
Current Opinion in Urology|April 5, 2012
Novel agents for the management of castration-resistant prostate cancerHousam Haddad, Jorge A Garcia
Current Oncology Reports|February 2, 2013
Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitorHui Zhu, Jorge A Garcia
Journal of Carcinogenesis|May 7, 2014
Novel agents in the management of castration resistant prostate cancerShruti Chaturvedi, Jorge A Garcia
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Therapeutic Advances in Medical Oncology|July 27, 2011
Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologistsJorge A Garcia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Systemic chemotherapy for advanced bladder cancer: update and controversiesJorge A Garcia, Robert Dreicer
Molecular Cancer Therapeutics|June 21, 2008
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesJorge A Garcia, David Danielpour
Nature Clinical Practice. Urology|February 14, 2006
Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversiesJorge A Garcia, Robert Dreicer
Current Opinion in Urology|March 26, 2009
Complications of androgen deprivation therapy in prostate cancerAnita Schwandt, Jorge A Garcia
Oncology (Williston Park, N.Y.)|May 10, 2011
Immunotherapy in castration-resistant prostate cancer: integrating sipuleucel-T into our current treatment paradigmJorge A Garcia, Robert Dreicer
Current Oncology Reports|January 19, 2011
Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancerMohamed Salem, Jorge A Garcia
Current Opinion in Urology|April 5, 2012
Novel agents for the management of castration-resistant prostate cancerHousam Haddad, Jorge A Garcia
Current Oncology Reports|February 2, 2013
Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitorHui Zhu, Jorge A Garcia
Journal of Carcinogenesis|May 7, 2014
Novel agents in the management of castration resistant prostate cancerShruti Chaturvedi, Jorge A Garcia
Pageof 17